Argenx Se (ARGX) Retained Earnings (2015 - 2026)

Argenx Se (ARGX) posted quarterly Retained Earnings of $1.4 billion for Q2 2026, up 100.12% year-on-year from $702.6 million in Q2 2025, and up 10.71% on a QoQ basis from $1.3 billion in Q4 2025.

Argenx Se (ARGX) Retained Earnings (2015 - 2026) Analysis & Trends

Argenx Se (ARGX) has reported Retained Earnings for 12 consecutive years, with $1.4 billion the latest figure, recorded in Q2 2026.

  • Quarterly Retained Earnings rose 100.12% year-over-year to $1.4 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.4 billion (up 100.12% YoY) and the FY2025 annual result came in at $1.3 billion, up 180.8% from the prior year.
  • Retained Earnings rose to $1.4 billion in Q2 2026 per ARGX's latest filing, from $1.3 billion in the prior quarter.
  • Over the last five years, Retained Earnings for ARGX reached as high as $1.4 billion in Q2 2026 and fell as low as -$1157.0 billion in Q2 2025.
  • A 5-year average of -$129.7 billion and a median of -$2.1 billion in 2022 frame the typical range for Retained Earnings.
  • The largest YoY upside for Retained Earnings was 180.8% in 2025 against a maximum downside of 47368.16% in 2025.
  • Year by year, Retained Earnings stood at -$2.1 billion in 2022, then decreased by 13.98% to -$2.4 billion in 2023, then jumped by 34.64% to -$1.6 billion in 2024, then soared by 180.8% to $1.3 billion in 2025, then climbed by 10.71% to $1.4 billion in 2026.
  • According to Business Quant data, Retained Earnings over the past three periods registered $1.4 billion, $1.3 billion, and -$1157.0 billion for Q2 2026, Q4 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -527.87 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -27.89 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 12.91 Bn
4 NuCana 279.75 Bn 279.75 Bn - 115.82 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 14.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 11.90 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - -622,000.00
10 Alnylam Pharmaceuticals 35.71 Bn 32.70 Bn 959.66 Mn -24.89 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 1.41 Bn
Dec 31, 2025 1.27 Bn
Jun 30, 2025 -1,156.98 Bn
Dec 31, 2024 -1.57 Bn
Jun 30, 2024 -2.44 Bn
Dec 31, 2023 -2.40 Bn
Jun 30, 2023 -2.23 Bn
Dec 31, 2022 -2.11 Bn
Jun 30, 2022 -1.84 Bn
Dec 31, 2021 -1.40 Bn
Jun 30, 2021 -928.76 Mn
Dec 31, 2020 -980.34 Mn
Jun 30, 2020 -612.45 Mn
Dec 31, 2019 -378.45 Mn
Jun 30, 2019 -244.35 Mn
Dec 31, 2018 -193.00 Mn
Jun 30, 2018 -177.57 Mn
Dec 31, 2017 -145.14 Mn
Jun 30, 2017 13.53 Mn
Dec 31, 2016 -104.62 Mn